Skip to content
Choksi Asia logo

Choksi Asia

530427 BSE
Price unavailable

Choksi Asia (CHOKSI) share price was ₹215.00 at the 28 Oct 2026 close; market capitalisation ₹123 Cr; P/E (TTM) 23.60; sector Consumer Goods. The share price rose 116.4% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue fell 22.5% year on year to ₹9.22 Cr and net profit fell 10.3% year on year to ₹0.96 Cr (compared with Jun 2025). Promoters held 71.15% of Choksi Asia in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 60/100 (Good) as of 28 Oct 2026.

Close 28 Oct 2026 ₹215.00 +112.83 +110.43% 1Y

Key Fundamentals

MicrocapHousehold ProductsFMCG
Market Cap
₹123 Cr
P/E (TTM)
23.6
EBITDA
₹8.20 Cr
Return on Equity
12.67%
Debt to Equity
0.2
Book Value
₹64.40
EPS (TTM)
₹9.11
52W High
₹266.45
52W Low
₹100.10

Price-based figures as of 28 Oct 2026, 15:30 IST · EPS basis: Standalone · TTM

Peer Comparison

Healthcare › Consumer Goods › Household Products › Medical Equipment & Supplies

Poly Medicure
₹1,464.1047.0914,840 Cr4.780.24%10.18%13.33%2,115 Cr313 Cr
Fischer Medical Ventures
₹26.2969.181,721 Cr3.760.20%8.11%12.69%373 Cr24 Cr
Tarsons Products
₹308.15147.441,640 Cr2.580.66%2.26%4.82%468 Cr11 Cr
Q-Line Biotech
₹550.0026.071,283 Cr2.630.00%22.63%26.37%201 Cr34 Cr
Laxmi Dental
₹178.5031.82982 Cr4.040.00%10.83%11.51%289 Cr31 Cr
Hemant Surgical Industries
——832 Cr5.310.00%13.22%19.52%——
Choksi Asia (this company)
—23.60123 Cr3.341.18%12.67%18.40%48 Cr5 Cr
Median 7 companies₹308.1539.461,283 Cr3.760.20%10.83%13.33%331 Cr28 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

60 Good
Overall score

Data confidence 100/100

Category scores

Quality Good 57
Returns, margins, earnings quality 22% weight
Valuation Average 52
Cheap vs sector & own history 24% weight
Growth Good 56
Sales & profit trajectory 9% weight
Financial Health Strong 79
Solvency, leverage, coverage 9% weight
Momentum Strong 94
Trend strength, vol-adjusted 12% weight
Ownership Average 50
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

2
  • Company has reduced debt.
  • Company has delivered good profit growth of 22.8% CAGR over last 5 years

Weaknesses

3
  • Stock is trading at 3.14 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 11.5% over last 3 years.

Technical Indicators

Oscillators

Bullish

Bearish
1
Neutral
6
Bullish
2

Overall

Bullish

Bearish
2
Neutral
6
Bullish
11

Moving Averages

Bullish

Bearish
1
Neutral
0
Bullish
9

Growth Rate

Revenue Growth
31.35% lower than 3Y

change over 1 year

Net Income Growth
70.97% lower than 3Y

change over 1 year

Cash Flow Change
126%

change over 1 year

EBITDA Margin Change
15.68%

change over 1 year Operating margin 14.97% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
0.4
0.52
3.04
0.15
1.37
8.42
8.67
12.15
11.9
13.29
12.26
11.86
9.22
Expenses
0.77
1.15
3.23
0.56
1.09
7.45
8.95
10.91
10.51
11.69
10.47
9.86
7.84
Operating Profit
-0.37
-0.63
-0.19
-0.41
0.28
0.97
-0.28
1.24
1.39
1.6
1.79
2
1.38
OPM %
-92.5%
-121.15%
-6.25%
-273.33%
20.44%
11.52%
-3.23%
10.21%
11.68%
12.04%
14.6%
16.86%
14.97%
Other Income
0.38
0.2
0.47
0.25
0.19
0.24
0.82
0.23
0.29
0.29
0.52
0.31
0.29
Interest
0
0
0
0
0
0.13
0.12
0.09
0.1
0.14
0.09
0.09
0.04
Depreciation
0.04
0.04
0.05
0.04
0.04
0.04
0.05
0.04
0.06
0.08
0.05
0.07
0.09
PBT
-0.03
-0.47
0.23
-0.2
0.43
1.04
0.37
1.34
1.52
1.67
2.17
2.15
1.54
Tax %
0%
0%
-173.91%
-255%
16.28%
36.54%
40.54%
47.01%
28.95%
19.16%
1.38%
65.12%
37.66%
Net Profit
-0.03
-0.47
0.63
0.31
0.36
0.65
0.22
0.71
1.07
1.35
2.13
0.75
0.96
EPS (₹)
-0.08
-1.21
1.62
0.79
0.92
1.67
0.56
1.82
1.88
2.37
3.74
1.32
1.68
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
108
45.96
27.26
23.08
17.33
16
11.16
2.46
0.77
15.99
36.98
49.31
46.63
Expenses
106
43.4
26.31
21.77
17.75
17.42
12.85
3.92
2.21
16.01
33.17
42.52
39.86
Operating Profit
1.84
2.56
0.95
1.31
-0.42
-1.42
-1.69
-1.46
-1.44
-0.02
3.81
6.79
6.77
OPM %
1.7%
5.57%
3.48%
5.68%
-2.42%
-8.88%
-15.14%
-59.35%
-187.01%
-0.13%
10.3%
13.77%
14.52%
Other Income
0.07
0.4
0.43
0.74
1.64
1.06
4.58
1.14
1.16
2.1
1.58
1.4
1.41
Interest
1.56
0.37
0
0
0
0
0
0
0
0.4
0.48
0.42
0.36
Depreciation
0.44
0.41
0.39
0.22
0.21
0.17
0.19
0.17
0.16
0.18
0.18
0.27
0.29
PBT
-0.09
2.18
0.99
1.83
1.01
-0.53
2.7
-0.49
-0.44
1.5
4.73
7.5
7.53
Tax %
-577.78%
0.92%
22.22%
30.05%
14.85%
5.66%
29.26%
-12.24%
6.82%
7.33%
34.25%
28.93%
—
Net Profit
0.42
2.17
0.77
1.29
0.86
-0.56
1.91
-0.42
-0.48
1.39
3.1
5.33
5.19
EPS (₹)
1.08
5.56
1.97
3.31
2.21
-1.44
4.9
-1.08
-1.23
3.56
7.95
9.35
9.11
Div. Payout %
46.43%
17.97%
37.99%
22.67%
22.67%
0%
51.05%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
3.9
3.9
3.9
3.9
3.9
3.9
3.9
3.9
3.9
5.7
5.7
5.7
Reserves
8.31
10.01
10.99
11.92
12.42
11.62
13.53
12.09
11.62
22.37
25.79
31.02
Borrowings
6.43
0
0
0
0
0
0
0
0
9.21
10.16
7.31
Other Liabilities
17.09
22.45
20.8
20.88
20.91
20.08
3.79
2.42
2.53
4.51
5.53
3.4
Total Liabilities
35.73
36.36
35.69
36.7
37.23
35.6
21.22
18.41
18.05
41.79
47.18
47.43
Fixed Assets
8.81
8.5
8.03
7.81
7.51
7.34
6.12
5.95
5.79
14.95
15.58
16.39
CWIP
0
0
0
0
0
0
0
0
0
0
0
0
Investments
0
3.87
7.49
5.36
2.93
6.87
0.78
3.35
0
0
0
0
Other Assets
26.92
23.99
20.17
23.53
26.79
21.39
14.32
9.11
12.26
26.84
31.6
31.04
Total Assets
35.73
36.36
35.69
36.7
37.23
35.6
21.22
18.41
18.05
41.79
47.18
47.43
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
10.64
7.93
1.65
5.49
2.42
-2.52
-2.82
-0.56
-2.52
2.68
-2.87
0.74
Investing
-0.12
-0.17
-0.01
0
0.58
-0.01
1.96
-2.49
3.35
1.52
0.63
0.2
Financing
-11.45
-6.9
0
-0.35
-0.35
-0.24
0
-0.98
0
0.47
-1.2
-3.4
Net Cash Flow
-0.94
0.86
1.65
5.14
2.64
-2.77
-0.85
-4.02
0.83
4.67
-3.43
-2.46
Free Cash Flow
10.52
7.76
1.64
5.49
3
-2.53
-0.86
-0.56
-2.52
2.79
-3.69
-0.35
CFO/OP
578
308
174
422
-581
177
153
25
175
-13,400
-75
-9
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
32.77
63.45
78.86
106
103
108
32.71
89.02
180
81.72
82.22
70.02
Inventory Days
46.51
101
125
89.13
156
113
34.47
71.32
1,971
150
106
86.13
Days Payable
53.76
210
350
407
503
531
44.81
27.27
87.6
46.49
39.44
13.71
Cash Conversion Cycle
25.52
-44.96
-146
-211
-244
-311
22.37
133
2,064
185
149
142
Working Capital Days
4.05
-12.31
-74.85
-115
-139
-178
77.19
381
2,361
131
138
134
ROCE %
6%
15.67%
6.53%
9.64%
5.66%
-3.33%
16.39%
-2.93%
-2.79%
7.2%
13.2%
18.49%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Choksi Asia insights

60 extracted metrics + investor summaries across FY06–FY27.

Shareholding Pattern

FIIs0.18%Promot.71.15%Others6.20%Public22.48%As ofSep 2026

Documents

Frequently Asked Questions about Choksi Asia

What does Choksi Asia Ltd do?
Incorporated in 1992, Choksi Imaging Ltd manufactures and trades X-ray films that find application in medical imaging. In addition, it is engaged in the trading of various items used in the healthcare industry.
Where is Choksi Asia Ltd (CHOKSI) listed?
Choksi Asia Ltd trades under code 530427 on the BSE.
Which sector does Choksi Asia Ltd belong to?
Choksi Asia Ltd is classified under the Consumer Goods sector, in the Household Products industry.
What is the market capitalisation of Choksi Asia Ltd?
Choksi Asia Ltd has a market capitalisation of ₹122.62 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Choksi Asia Ltd?
Choksi Asia Ltd trades at a PE ratio of 23.60 as of 28 Oct 2026, on earnings per share of ₹9.11, against a book value of ₹64.4 per share.
What is the 52-week high and low of Choksi Asia Ltd?
Over the last 52 weeks Choksi Asia Ltd has traded between ₹100.1 and ₹266.45 as of 28 Oct 2026.
Does Choksi Asia Ltd pay dividends?
Choksi Asia Ltd has a dividend yield of 1.16%.
What is the Return on Equity (ROE) of Choksi Asia Ltd?
Choksi Asia Ltd reported a return on equity of 12.67%. Its debt-to-equity ratio is 0.20.

Company Information

Incorporated in 1992, Choksi Imaging Ltd manufactures and trades X-ray films that find application in medical imaging. In addition, it is engaged in the trading of various items used in the healthcare industry.

Website choksiworld.com
Face Value ₹ 10
Shares Outstanding 57,03,232

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/530427.md for Choksi Asia Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Healthcare Equipment stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month